Section 1. Report Objective, and Methodology
- Scope of Research
- Research Methodology
- Assumptions
- Research Sources
- Primary Research
- Secondary Research
- Paid Databases
Section 2. Report Summary
- Global Market Snapshot, 2022-2030
- Executive Summary by Segments
- Market Overview, By Treatment Type
- Market Overview, By Distribution Channel
- Market Overview, By Region
Section 3. Key Insights
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Developments
- Major Brand Analysis
- Price Trend Analysis
- Pipeline Analysis
- Porter’s Analysis
- Epidemiology
- Technology Insights
- Impact of COVID-19
Section 4. Global Acute Myeloid Leukemia Treatment Market, By Treatment Type, Market Size, and Revenue Opportunity (USD Million, 2022-2030)
- Global Industry Overview, By Treatment Type
- Market Size, US$ Mn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Chemotherapy (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Targeted Therapy (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
Section 5. Global Acute Myeloid Leukemia Treatment Market By Distribution Channel, Market Size, and Revenue Opportunity (USD Million, 2022-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Mn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Hospital Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Specialty Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Online Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
Section 6. Global Acute Myeloid Leukemia Treatment Market By Region, Market Size, and Revenue Opportunity (USD Million, 2022-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Mn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- North America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- U.S.
- Canada
- Latin America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Brazil
- Mexico
- Rest of Latin America
- Europe
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- China
- Japan
- South Korea
- India
- ASEAN
- Rest of APAC
- Middle East and Africa
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022–2030, (US$ Million))
- Saudi Arabia
- UAE
- Rest of MEA
Section 7. Company Profiles
- Jazz Pharmaceuticals
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Pfizer, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- AstraZeneca
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Novartis AG
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Takeda Pharmaceutical Company
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- AbbVie Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Bristol Myers Squibb
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Daiichi Sankyo
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Rafael Pharmaceuticals Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Agios Pharmaceuticals
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Rigel Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
Frequently Asked Questions
Current market size: US$ 1222.2 Mn
Factors contributing to growth: Rising prevalence of AML and increasing adoption of novel therapies
Key factors hampering growth: High cost of treatment and limited access to care
Leading component segment: Chemotherapy drugs
Major players: Pfizer, Novartis, AbbVie, Celgene, Amgen
CAGR and market size by 2030: 11.9% and US$ 2,685.1 Mn by 2030